Transcription of Veritor™ System For Rapid Detection of SARS-CoV-2
{{id}} {{{paragraph}}}
Example: bachelor of science
Veritor™ System For Rapid Detection of SARS-CoV-2
30 Determinations 256082 30 C500048916(05) 2021-01 2 C Veritor System For Rapid Detection of SARS-CoV-2 Kit configured for testing nasal swab samples freshly collected, processed and dispensed directly onto assay test device. For use under an Emergency Use Authorization only, in the United States. Becton, Dickinson and Company7 Loveton Circle Sparks, Maryland 21152 USA BD, the BD logo, and Veritor are trademarks of Becton, Dickinson and Company or its affiliates. All other trademarks are the property of their respective owners. 2021 BD. All rights Veritor System For Rapid Detection of SARS-CoV-2 Kit configured for testing nasal swab samples freshly collected, processed and dispensed directly onto assay test device. For In Vitro Diagnostic Use.
The BD Veritor™ System for Rapid Detection of SARS-CoV-2 is a rapid (approximately 15 minutes) chromatographic digital immunoassay for the direct detection of the presence or absence of SARS-CoV-2 antigens in respiratory specimens taken from patients with signs and symptoms who are suspected of COVD-19. The test is intended for interpretation in
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: